Moderna to Present at Upcoming Conferences in September 2025
Moderna (NASDAQ:MRNA) has announced its participation in two major healthcare investor conferences in September 2025. The company will present at the Morgan Stanley's 23rd Annual Global Healthcare Conference on September 8th at 10:00am ET and at Bernstein Insights: Healthcare Leaders and Disruptors on September 25th at 10:30am ET.
Investors can access live webcasts of both presentations through the "Events and Presentations" section of Moderna's investor website. The webcasts will remain archived on the company's website for a minimum of 30 days after each presentation.
Moderna (NASDAQ:MRNA) ha comunicato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario previste a settembre 2025. L'azienda presenter脿 al Morgan Stanley's 23rd Annual Global Healthcare Conference l'8 settembre alle 10:00 ET e al Bernstein Insights: Healthcare Leaders and Disruptors il 25 settembre alle 10:30 ET.
Gli investitori potranno seguire entrambe le presentazioni in diretta tramite la sezione 芦Eventi e presentazioni禄 del sito investor di Moderna. Le webcast resteranno archiviate sul sito della societ脿 per almeno 30 giorni dopo ogni presentazione.
Moderna (NASDAQ:MRNA) ha anunciado su participaci贸n en dos importantes conferencias para inversores del sector sanitario en septiembre de 2025. La compa帽铆a presentar谩 en el Morgan Stanley's 23rd Annual Global Healthcare Conference el 8 de septiembre a las 10:00 ET y en Bernstein Insights: Healthcare Leaders and Disruptors el 25 de septiembre a las 10:30 ET.
Los inversores podr谩n acceder a las retransmisiones en vivo de ambas presentaciones a trav茅s de la secci贸n 芦Eventos y presentaciones禄 del sitio web para inversores de Moderna. Las retransmisiones quedar谩n archivadas en la web de la compa帽铆a durante un m铆nimo de 30 d铆as tras cada presentaci贸n.
Moderna (NASDAQ:MRNA)電� 2025雲� 9鞗旍棎 鞐措Μ電� 霊� 臧滌潣 欤检殧 鞚橂 韴瀽鞛� 旎嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� Morgan Stanley's 23rd Annual Global Healthcare Conference鞐愳劀 9鞗� 8鞚� 鞓れ爠 10:00 ET鞐� 氚滍憸頃橂┌, Bernstein Insights: Healthcare Leaders and Disruptors鞐愳劀電� 9鞗� 25鞚� 鞓れ爠 10:30 ET鞐� 氚滍憸頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚� Moderna 韴瀽鞛� 鞗轨偓鞚错姼鞚� "鞚措菠韸� 氚� 頂勲爤鞝犿厡鞚挫厴" 靹轨厴鞚� 韱淀暣 霊� 氚滍憸鞚� 鞁れ嫓臧� 鞗轨簮鞀ろ姼毳� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼電� 臧� 氚滍憸 頉� 斓滌唽 30鞚� 霃欖晥 須岇偓 鞗轨偓鞚错姼鞐� 鞎勳勾鞚措笇搿� 氤搓磤霅╇媹雼�.
Moderna (NASDAQ:MRNA) a annonc茅 sa participation 脿 deux grandes conf茅rences pour investisseurs dans le secteur de la sant茅 en septembre 2025. La soci茅t茅 pr茅sentera lors du Morgan Stanley's 23rd Annual Global Healthcare Conference le 8 septembre 脿 10h00 ET et lors de Bernstein Insights: Healthcare Leaders and Disruptors le 25 septembre 脿 10h30 ET.
Les investisseurs pourront acc茅der aux webcasts en direct des deux pr茅sentations via la rubrique 芦 脡v茅nements et pr茅sentations 禄 du site investisseurs de Moderna. Les webcasts resteront archiv茅s sur le site de la soci茅t茅 pendant au moins 30 jours apr猫s chaque pr茅sentation.
Moderna (NASDAQ:MRNA) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Gesundheitswesen im September 2025 angek眉ndigt. Das Unternehmen wird am Morgan Stanley's 23rd Annual Global Healthcare Conference am 8. September um 10:00 Uhr ET und beim Bernstein Insights: Healthcare Leaders and Disruptors am 25. September um 10:30 Uhr ET pr盲sentieren.
Investoren k枚nnen beide Pr盲sentationen live 眉ber den Bereich 鈥濫vents and Presentations鈥� auf Modernas Investorenseite verfolgen. Die Webcasts werden nach jeder Pr盲sentation mindestens 30 Tage lang auf der Website des Unternehmens archiviert.
- None.
- None.
CAMBRIDGE, MA / / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the following upcoming investor conferences:
Morgan Stanley's 23rd Annual Global Healthcare Conference, on Monday, September 8th at 10:00am ET
Bernstein Insights: Healthcare Leaders and Disruptors, on Thursday, September 25th at 10:30am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.
.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
础产辞耻迟鈥疢辞诲别谤苍补
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original on ACCESS Newswire
FAQ
When is Moderna presenting at the Morgan Stanley Healthcare Conference 2025?
When is Moderna's presentation at the Bernstein Insights conference?
How can investors access Moderna's September 2025 conference presentations?
How long will Moderna's conference webcasts be available for replay?
